A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pegfilgrastim in Patients Receiving First-Line FOLFOX/Bevacizumab or FOLFIRI/Bevacizumab for Locally Advanced or Metastatic Colorectal Cancer: Final Results of the Pegfilgrastim and Anti-VEGF Evaluation Study (PAVES)
Titel:
A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pegfilgrastim in Patients Receiving First-Line FOLFOX/Bevacizumab or FOLFIRI/Bevacizumab for Locally Advanced or Metastatic Colorectal Cancer: Final Results of the Pegfilgrastim and Anti-VEGF Evaluation Study (PAVES)
Auteur:
Pinter, Tamás Klippel, Zandra Cesas, Alvydas Croitoru, Adina Decaestecker, Jochen Gibbs, Peter Hotko, Yevhen Jassem, Jacek Kurteva, Galina Novotny, Jan O'Reilly, Seamus Salek, Tomas Reiner, Maureen Morrow, Phuong Khanh Choi, Mi Rim Whittaker, Sadie Blanke, Charles